On Tuesday, Symantec Corporation (NASDAQ:SYMC)’s shares inclined 0.82% to $19.74.
SYMC offered 7.70% EPS for prior five years. The company has 11.40% return on equity value while its ROI ratio was 11.60%. The company has $13.18 billion market capitalizations and the institutional ownership was 93.00%. Its price to book ratio was 2.28. Volatility of the stock was 1.51% for the week while for the month booked as 2.01%. The mean estimate for the short term price target for Symantec Corporation (NASDAQ:SYMC) stands at $23.25 according to 20 Analysts. The higher price target estimate for the stock has been calculated at $25.00 while the lower price target estimate is at $19.00. Symantec Corporation (NASDAQ:SYMC) provides security, backup and availability solutions. The Company operates in three segments: Consumer Security, Enterprise Security, and Information Management.
Staples, Inc. (NASDAQ:SPLS)’s shares gained 0.91% to $12.18.
SPLS has beta value of 1.36. The company has the market capitalization of $7.93 billion. Return on assets ratio of the company was 0.30% while its return on equity ratio was 0.60%. ATR value of company was 0.37 while stock volatility for week was 2.15% while for month was 3.13%. Debt to equity ratio of the company was 0.19 and its current ratio was 1.60. The mean estimate for the short term price target for Staples, Inc. (NASDAQ:SPLS) stands at $17.46 according to 13 Analysts. The higher price target estimate for the stock has been calculated at $23.00 while the lower price target estimate is at $12.00. Staples, Inc. (NASDAQ:SPLS) is a provider of products and services that serve the needs of business customers and consumers. The Company offers a selection of products, such as Websites and mobile platforms, retail and online shopping and a range of copy and print and technology services.
At the end of Tuesday’s trade, Oncothyreon Inc (USA) (NASDAQ:ONTY)‘s shares dipped -1.69% to $3.49.
ONTY has market value of $321.32 million while its EPS was booked as $-0.54 in the last 12 months. The stock has 94.93 million shares outstanding while 65.00% shares of the company were owned by institutional investors. Beta value of the company was 1.08; beta is used to measure riskiness of the security. The mean estimate for the short term price target for Oncothyreon Inc (USA) (NASDAQ:ONTY) stands at $4.75 according to 4 Analysts. The higher price target estimate for the stock has been calculated at $5.00 while the lower price target estimate is at $4.00. Oncothyreon Inc (USA) (NASDAQ:ONTY) is a clinical-stage biopharmaceutical company focused primarily on the development of therapeutic products for the treatment of cancer. The Company’s clinical-stage product candidates include ONT-380, an orally active and selective small-molecule HER2 inhibitor, and ONT-10, a therapeutic vaccine targeting the Mucin 1 peptide antigen.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.